(VIEW press/Corbis News/Getty Images) … The drug was originally tested at an 80-mg monthly dose in the three clinical trials supporting its FDA …
ASH: Pfizer’s Hympavzi reduces bleeding in hemophilia patients – Fierce Pharma
Share This Story, Choose Your Platform!
About the Author: AJDesign77
